BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

BrainsWay Ltd.NASDAQ: BWAY

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash turns negative

Q1 FY2026 net change in cash was -$9.06M, compared with $2.26M a year earlier. Trailing-twelve-month net change in cash was -$12.97M.

Context

  • Net change in cash amounted to 3.2% of revenue in FY2025, down 140.2 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly net change in cash holds near -$9.06M or moves back toward the trailing-twelve-month quarterly average of -$3.24M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.06M+228.5% QoQ
Last fiscal yearDec 2025
-$1.67M-102.8% YoY
LTMMar 2026
-$12.97M-121.9% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-501.8%——
1 year-102.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(1.67M) USD
Year-over-year change
-102.8%

Net Change in Cash vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's LTM Mar 2026 net change in cash of $12.97M is the largest of the 4 companies compared; the peer median is $2.26M.
  • Its year-over-year change of -121.9% is the 3rd highest of 4, against a peer median of -91.5%.
  • Net change in cash amounts to 23.1% of revenue for BWAY, versus a peer median of 12.3%.
BWAY Competitors Peer median
Net Change in Cash for BWAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BWAYBrainsWay Ltd.LTM Mar 2026$12.97M -121.9%—23.1%
NPCENeuroPace, Inc.LTM Mar 2026$12.24M -187.3%—12.3%
HSDTSolana CompanyLTM Mar 2026$3.29M +229.9%+20.5%34.3%
STIMNeuronetics, Inc.LTM Mar 2026$2.26M -91.5%—1.5%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding BWAY) $2.26M-91.5%+20.5%12.3%

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(6.46M)(13.35M)(4.2M)2.92M7.63M
Depreciation & Amortization1.69M1.53M1.34M1.77M1.54M
Deferred Income Tax43K315K251K538K77K
Stock-Based Compensation1.89M1.47M381K1.44M1.2M
Change in Working Capital1.07M(1.45M)1.64M2.39M8.23M
Accounts Receivables(849K)1.46M1.09M(867K)611.82K
Inventory(411K)(3.6M)(506K)(920K)(1.41M)
Accounts Payables289K0(327K)2.12M(480.78K)
Other Working Capital2.04M685K1.38M2.06M9.52M
Other Non-Cash Items2.66M1.72M1.88M1.24M(506.79K)
Operating Cash Flow884K(9.76M)1.28M10.3M18.16M
Capital Expenditures(2.24M)9.72M(2.39M)(3.79M)(1.76M)
Acquisitions (Net)39.98M0000
Purchases of Investments(40M)(21K)00(15.89M)
Sales of Investments22K40.25M0020.16K
Other Investing Activities(39.98M)0(35.02M)35.08M0
Investing Cash Flow(42.22M)42.17M(37.41M)30.31M(17.63M)
Debt Repayment(475K)(533K)(271K)(424K)(832K)
Common Stock Issued42.26M0016.35M0
Common Stock Repurchased0(52K)000
Dividends Paid00000
Other Financing Activities(269K)(962K)(755K)2.33M(1.4M)
Financing Cash Flow41.52M(1.55M)(1.03M)18.26M(2.23M)
Effect of Forex Changes(224K)(202K)90K(47K)34.35K
Net Change in Cash(40K)30.66M(37.06M)58.83M(1.67M)
Free Cash Flow(1.35M)(9.76M)(1.1M)6.5M16.4M

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.